Skip to main content
Signal8

Restart Life Sciences Corp. (NMLSF)

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company has collaboration with the University of Manitoba's Richardson Centre for food technology and research (RCFTR) to support a series of food-related scientific studies. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.

Sector: Biotechnology

Industry: Biotechnology

Restart Life Sciences Corp. logo

Restart Life Sciences Corp.

OTC:NMLSFHealthcare
+313.73%$0.0633
CLOSED
Mkt Cap$2.01M
EV-
Float28.26M
O/S31.76M
VOL2K sh
$ Vol$118
RVOL3.16×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
Restart Life Sciences Corp. logoOTC:NMLSFClosed$0.0633+313.73%
Short interest (FINRA)
0.0%
Oct 30 (18d)

Float 28.26M · FMP free float

1
Oct 30 (18d)prev 1– 0.0%
1.00
Oct 30 (18d)prev 1.00– 0.0%
Borrow (IBKR)

The cost to borrow NMLSF shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
3.4%
Sep 28 (50d)prev 85.7%▼ 82.3 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

No fails on record for 16–31 Oct 2026.
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 20261 sh
Oct 15, 20261 sh
Sep 30, 20261 sh
Sep 15, 20261 sh
Aug 31, 20261 sh

A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Sep 28
Latest sessions
DateReported short
Sep 28, 20263.4%
Aug 6, 202685.7%
Aug 5, 20265.7%
Aug 3, 20267.3%
3-session median 7.3%mean 32.9%range 5.7–85.7%

130 calendar days requested; 4 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for NMLSF: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 1 NMLSF shares were sold short (<0.01% of a 28.26M-share float, 1.00 days to cover).